Table 1 Patients baseline characteristics (n(%))
Characteristics | olanzapine (n=94) | aprepitant (n=96) | P |
|---|---|---|---|
Age(years) | 59.44±9 | 59.65±9.968 | 0.406 |
≥55 | 72(76.60) | 71(73.96) | 0.674 |
Gender | 0.643 | ||
Female | 38(40.43) | 42(43.75) | |
Male | 56(59.57) | 54(56.25) | |
History of motion sickness | 16(17.02) | 13(13.54) | 0.505 |
History of female pregnancy vomiting | 5(5.32) | 10(10.41) | 0.193 |
Alcohol use | 0.598 | ||
No Consumption | 50(53.19) | 44(45.83) | |
<4 drinks per week | 27(28.72) | 32(33.33) | |
≥4drinks per week | 17(18.09) | 20(20.83) | |
Smoking Index | 0.508 | ||
No Smoking | 35(37.23) | 42(43.75) | |
0~400 | 13(13.83) | 9(9.38) | |
≥400 | 46(48.94) | 45(46.87) | |
Type of malignance | 0.735 | ||
Lung cancer | 34(36.17) | 37(38.54) | |
Others | 60(63.83) | 59(61.46) | |
Chemotherapy Cycle | 0.378 | ||
First- Cycle | 23(24.47) | 31(32.29) | |
Second - Cycle | 28(29.79) | 22(22.92) | |
Third - Cycle | 15(15.56) | 20(20.83) | |
≥Fouth- Cycle | 28(29.78) | 23(23.96) |